Figure 4.

Estimated Rate of Patients Free from Local Biopsy-proven Acute Rejection (Kaplan-Meier Method). Differences in the estimated rate of patients free from biopsy proven acute rejection at week 24 between the high level FK778 (62.3%) vs. MMF (82%) groups were significant (Pā€‰=ā€‰0.014, Chi-square test). Differences between the two treatment groups were also significant at month 12 when estimated rates were 62.3% in the high level FK778 vs. 79.4% in the MMF group (Pā€‰=ā€‰0.023, Chi-square test).

Wlodarczyk et al. BMC Nephrology 2012 13:68   doi:10.1186/1471-2369-13-68
Download authors' original image